3M Stock Is Higher Despite Its Dividend Cut. Here's Why
3M is snapping its decades-long streak of dividend hikes, yet it's been one of the best Dow Jones stocks this week. Here's what you need to know.


3M (MMM) stock gained nearly 5% Tuesday and is up another 3% Wednesday, making one of the best-performing best Dow Jones stocks so far this week. The upside comes as the Post-It note maker's first-quarter earnings and revenue beat offset news that MMM is cutting its dividend, putting an end to its six-decade streak of increases.
In the three months ended March 31, 3M said revenue increased 0.5% year-over-year to $7.7 billion and earnings per share (EPS) were up 21.3% to $2.39.
The results exceeded analysts' expectations for revenue of $7.1 billion and EPS of $1.96, according to Yahoo Finance.
From just $107.88 $24.99 for Kiplinger Personal Finance
Be a smarter, better informed investor.

Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The quarterly results were the last for outgoing CEO Mike Roman. In March, the company announced Roman will be replaced on May 1 by former L3Harris Technologies (LHX) CEO William Brown. Roman will become executive chairman of 3M's board.
3M cuts its dividend
On April 1, 3M completed the spinoff of its healthcare business, Solventum (SOLV). The company retains a 19.9% ownership stake the new business, which it will monetize over the next five years. However, as a result of the spinoff, 3M said it will reset its dividend payout ratio to approximately 40% of adjusted free cash flow. This will result in a cut to its shareholder payout.
The dividend cut had been anticipated by many firms, including CFRA Research.
"Despite the expected cash infusion from the Solventum spinoff, we believe that 3M is likely to cut its dividend over the next 12 months," said CFRA Research analyst Jonathan Sakraida in an April 16 research note. In addition, the company is facing upcoming litigation payouts related to "forever chemicals."
Investors will find out how deep the dividend cut will be next month, but speculation is already swirling.
"3M generally converts 100% of reported earnings to free cash flow," wrote Al Root, senior writer at Barron's, in an April 30 article. "That implies 2024 free cash flow, after the Solventum spin, of roughly $4 billion. Doing the math, 40% of that total is about $1.6 billion, or roughly $2.85 a share."
An annual dividend of $2.85 per share would be a 52.8% reduction from 3M's current annual rate of $6.04 per share.
Unfortunately, the dividend cut puts 3M at risk of losing its status as a Dividend Aristocrat, the best dividend stocks in the S&P 500 that have consistently raised their annual payouts for 25 straight years.
According to 3M, it has raised its annual dividend for 64 consecutive years and has paid a dividend for the past 100.
Where does 3M stand with analysts?
Analysts are mixed on the multinational conglomerate. According to S&P Global Market Intelligence, the consensus analyst target price for the blue chip stock is $101.24, representing implied upside of just nearly 2% to current levels. Additionally, the consensus recommendation is a Hold.
Argus Research analyst John Eade is one of those with a Hold rating on 3M stock. "The company is now taking aggressive steps to engineer an earnings and stock price turnaround," Eade says, including bringing on a new CEO and cutting its dividend to conserve cash. These are all good things, but "we expect that a return to industry leadership will take time and will look for top-line progress as a potential buying signal," he adds.
Related Content
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Stock Market Winners and Losers of the 'Big, Beautiful' Bill
Defense, manufacturing and tech should prosper, while health care and green energy stocks face hurdles.
-
I'm a Financial Planner: Here's How to Invest Like the Wealthy, Even if You Don't Have Millions
Private market investments, once exclusive to the ultra-wealthy and institutions, have become more accessible to individual investors, thanks to regulatory changes and new investment structures.
-
Four Ways a Massive Emergency Fund Can Hurt You More Than It Helps
Saving too much could mean you're missing opportunities to put your money to work. Redirect some of that money toward paying off debt, building retirement funds, fulfilling a dream or investing in higher-growth options.
-
With Buffett Retiring, Should You Invest in a Berkshire Copycat?
Warren Buffett will step down at the end of this year. Should you explore one of a handful of Berkshire Hathaway clones or copycat funds?
-
I'm a Financial Planner: How to Dodge a Retirement Danger You May Not Have Heard About
Timing is everything, and sequence of returns risk can mean the difference between a retirement nest egg that's overflowing … or empty.
-
Caring for Aging Parents: An Expert Guide to Easing the Financial and Emotional Strain
Early conversations, financial planning and understanding the progression of care needs can help to mitigate stress and protect family relationships.
-
Dow Adds 238 Points as UNH, CAT Pop: Stock Market Today
The lack of a September jobs report didn't seem to worry market participants, with the data delayed due to the ongoing government shutdown.
-
I'm a Financial Adviser: The OBBB Is a Reminder for Older People to Have a Long-Term Plan
The new tax bill presents a good opportunity for retirees to revisit tax plans, look into doing some Roth conversions and consider plans for long-term care.